CIRRHOSIS of the liverHEPATITIS BHEPATITIS CHEPATOCELLULAR carcinomaCHRONIC hepatitis BLIVER diseasesTERTIARY careObjective: Liver cirrhosis is one of the most widespread diseases in underdeveloped countries. Study Design: Cross Sectional Study. Setting: Nishtar Hospital Multan. Perio...
Varicose veins in the esophagus and stomach are caused by increased pressure in theportalvein, mainly due to cirrhosis. As a result of liver scarring, the flow of portal venous blood through the liver vein is impeded, so that bypass circuits such asvaricose veins(varices) form. Internal blee...
Continuous terlipressin infusion in patients with persistent septic shock and cirrhosis of the liver We read with interest the report by Dr. Morelli et al. concerning the use of continuous low-dose terlipressin (TP) in patients with septic shock .Circulato... A Umgelter,W Reindl,RM Schmid,....
In the more severe liver disease, such as late hepatitis, cirrhosis of the liver, and heavy detoxification function receded, intimate toxic substances will be accumulated, and not only to other organs have also further aggravate damage liver damage ...
Values for both % 13 C dose h 1 and % 13 C cumulative excretion decreased during his clinical course. We confirmed that PBT was useful for following the course of LC. 展开 关键词: L-[1-13C] phenylalanine breath test liver cirrhosis ...
Treatment of hepatocellular carcinoma associated with cirrhosis in the era of liver transplantation. To review the treatment of cirrhotic patients with hepatocellular carcinoma in the era of liver transplantation and to determine the most appropriate appro... E Mor,R Turkaspa,P Sheiner,... - 《...
The best examples of this are in primary biliary cirrhosis and primary sclerosing cholangitis, for which well-validated disease-specific models of natural history are available. There are currently relatively few absolute contraindications to liver transplantation. These include severe cardiopulmonary disease...
The next step will be a larger clinical trial, which if successful could see DIALIVE approved forclinical usewithin the next three years. Worldwide, it is estimated that there are around 100 million people living with cirrhosis of the liver and 10 million who have cirrhosis plus an additional...
Non-alcoholic fatty liver disease (NAFLD) is the leading cause of cirrhosis and hepatocellular carcinoma (HCC), occurring in 25% of the global population [1]. Over the past ten years, significant conceptual advances have been made in understanding the complex pathophysiological mechanisms of this ...
A case of severe hypophosphatemia related to adefovir dipivoxil treatment in a patient with liver cirrhosis related to hepatitis B virus Adefovir dipivoxyl (ADV) effectively suppresses hepatitis B virus (HBV) replication but exhibits nephrotoxicity with severe hypophosphatemia when administe... HJ Lee,...